Back to Search
Start Over
Analgesic eluting bone cement: A novel approach for targeted pain management in total knee arthroplasty - An in-vitro study.
- Source :
-
The Knee [Knee] 2024 Aug; Vol. 49, pp. 135-146. Date of Electronic Publication: 2024 Jun 28. - Publication Year :
- 2024
-
Abstract
- Background: The average rate of patient dissatisfaction following total knee arthroplasty (TKA) is 10%. Multi-modal analgesia is the present standard of pain management after TKA. Studies show that with multi-modal analgesia, approximately 60% of patients experience severe knee pain following surgery, while around 30% experience moderate pain. To date, there is no literature available on targeted pain management using bone cement.<br />Objectives: To investigate the feasibility of incorporating anti-inflammatory medications and identify the analgesic with the best release pharmacokinetics from bone cement for application in pain management.<br />Methods: In an in-vitro study, 100 mg of five drugs (aceclofenac, diclofenac, naproxen, paracetamol and methyl prednisolone) were incorporated into bone cement (Palacos). Cement cubes holding each drug were made and allowed to harden for 30 min. Each drug-containing cube was placed in a beaker with saline for 72 h. Fractions of 10 ml were collected at 0, 6, 24, 48 and 72 h and analysed using high-pressure liquid chromatography to measure the percentage release of the drug from bone cement.<br />Results: Naproxen showed superior elution from bone cement, with 10.9% at 24 h and 9.08% at 72 h. Paracetamol showed 4.9% at 24 h and 3.78% at 72 h, aceclofenac 0.2% at 24 h and 0.4% at 72 h, diclofenac 3.03% at 24 h and 1.99% at 72 h, and methylprednisolone 0.26% at 24 h and 0.32% at 72 h.<br />Conclusions: Polymethylmethacrylate bone cement can elute analgesics in vitro. Among the five drugs studied, naproxen had the best release kinematics from polymethylmethacrylate bone cement. Analgesic eluting bone cement is a novel approach for targeted postoperative pain management in TKA.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Subjects :
- Humans
Analgesics administration & dosage
Analgesics therapeutic use
Acetaminophen therapeutic use
Acetaminophen administration & dosage
Polymethyl Methacrylate
Anti-Inflammatory Agents, Non-Steroidal administration & dosage
Methylprednisolone administration & dosage
Methylprednisolone analogs & derivatives
In Vitro Techniques
Arthroplasty, Replacement, Knee
Bone Cements
Diclofenac administration & dosage
Diclofenac analogs & derivatives
Pain, Postoperative drug therapy
Naproxen administration & dosage
Pain Management methods
Subjects
Details
- Language :
- English
- ISSN :
- 1873-5800
- Volume :
- 49
- Database :
- MEDLINE
- Journal :
- The Knee
- Publication Type :
- Academic Journal
- Accession number :
- 38943788
- Full Text :
- https://doi.org/10.1016/j.knee.2024.05.012